Your QM routine falls behind, and batch release stalls.
Overdue PQRs, a backlog of deviations, CAPAs that no one can keep up with, and no hands to work through them reliably. A&O Pharma takes on your operational QM work with named points of contact and statutory roles (Qualified Person under § 14 AMG, Head of Quality Control or Head of Production) in-house, so your process quality remains continuously assured and your team gets some breathing room back.
Non-binding and confidential. Answer in one to two working days.
§ 14 AMG / § 12 AMWHV
Qualified Person and responsible personnel in-house
ICH Q10
Pharmaceutical quality system, in practice
2 locations
Efringen-Kirchen and Itzehoe, owner-managed
Every unprocessed deviation and every overdue PQR is an open risk in your system, and a defective product costs more than the quality work that would have prevented it.
The question that matters
Do you take on the work, or only the responsibility for it?
The work. Deviations, CAPA, change control and Product Quality Reviews are actually processed by us, in your system and according to your SOPs, not as advice on how it could be done. Final approval remains with your QM management, unless you have us fill that role as well through our interim management service. This gives you additional capacity without blurring responsibilities, and your team gets breathing room back for what only they can do internally.
A quality management system relies on several tools that, together, ensure and continually improve the quality of your products. Effective, continuous quality assurance lowers quality-related costs, because expenses caused by defective products are avoided. This only succeeds, however, if the tools are established at every level and actually applied. This is precisely where things most often fall behind in day-to-day business.
These processes we take on for you
Product Quality Reviews: annual assessment of product quality, including trend analysis.
Supplier qualification: risk-based qualification and monitoring of your suppliers and contractors.
Self-inspections: planning, conduct and follow-up of internal audits.
Quality risk management: structured risk assessment following an established approach.
CAPA management: corrective and preventive actions, from root cause analysis to effectiveness verification.
Change management: assessment, approval and documentation of changes.
Deviations: processing, assessment and closure, including OOS investigations.
Complaint handling: intake, assessment and response.
Knowledge management: capture and transfer of process knowledge.
Management review: preparation of key figures and support for the leadership's assessment.
The regulatory framework
EU GMP Guide Part I, Chapter 1 on the pharmaceutical quality system.
ICH Q9 on quality risk management.
ICH Q10 on the pharmaceutical quality system, including management review.
Self-inspection under Chapter 9 of the EU GMP Guide.
Process
From the enquiry to the elimination of left-behind tasks.
What is outstanding, how old, what carries the highest priority. Where it hurts most.
02
Setting the order
First the genuine risks, then the finer points.
03
Working through your system
We work according to your SOPs and your tools, so nothing is maintained twice.
04
Handover or ongoing operation
Either handed back to your team, cleanly documented, or we keep the area running on an ongoing basis.
Typical initial situations
Does one of these sound familiar?
PQR backlog
The annual product quality review is overdue, in some cases for several products. This is the first item checked in an audit.
Deviations piling up
Open cases keep getting older instead of being closed. Each one is a documented risk within your own system.
Vacancy in quality management
Someone has left and ongoing processes do not wait for a replacement to be hired.
Self-inspections left undone
The plan exists, but no one has the time. Self-inspections not carried out are a recurring audit finding.
Responsibility
Who stands up for it here.
You get the name, the legal role and the extension of the person who takes over your topic. Before the start of the contract, not afterwards, and not as a team, but as a person.
Dr. Olaf Mundszinger
Founder and Managing Director
QP
Key areas
Pharmaceutical quality control and quality assurance
Person responsible for narcotics
IMPD preparation
Pharmaceutical analytics
Doctorate in analytical chemistry, degree in pharmaceutical sciences and chemistry
Can you take on individual QM tasks, or only the whole package?
Both. You can book individual building blocks, for example only the annual Product Quality Review, only supplier qualification, or only self-inspections, or outsource your entire operational QM function on an ongoing basis. In the scoping conversation, we clarify which arrangement fits your needs and capacity.
Do you work in our QM system or your own?
As a rule, we work within your system, so that records, documentation and responsibilities stay where they belong. We adapt to your SOPs and your document control system. Where you do not yet have a suitable system, we support you in building one.
Do we need a Qualified Person for operational QM support?
For most operational QM work, PQR, deviations, CAPA, self-inspections, supplier qualification, a dedicated Qualified Person is not strictly required; we provide these services independently. Where your quality system requires involvement of the Qualified Person under § 14 AMG, we coordinate with your QP or provide this role from our organisation.
How quickly can you step in with an existing backlog?
After a brief scoping conversation, we typically prepare a concrete proposal with a timeline and a named point of contact within a few days. For acute backlogs, for example open deviations with deadlines or an overdue PQR, we prioritise the start accordingly, so that nothing remains unprocessed.
Is outsourced QM support worthwhile compared with our own staff?
Where demand fluctuates, positions are vacant, or individual tasks are particularly time-consuming, usually yes. You get experienced QM specialists exactly when you need them, without maintaining permanent full-time positions. In addition, effective QM assurance lowers costs, because defective products are avoided. Where volume is consistently high, your own personnel may be more sensible, and we assess that honestly with you in conversation.
Who is liable when you take on our QM work?
Overall responsibility for your quality system remains with you and your management, as required by pharmaceutical law. Unlike with a staffing agency, however, you receive from us a named, professionally experienced point of contact who can also draw on the expertise of our entire organisation. For specialist questions, our full team stands behind them. Responsibilities and interfaces are set out clearly in the contract.
As a member of the Life Science Nord cluster, we benefit from a strong, innovative network and work with other experts in the industry on forward-looking developments.